Atypical antipsychotic drugs in the treatment of manic syndromes in patients with HIV-1 infection
- 1 March 1995
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 9 (2) , 151-154
- https://doi.org/10.1177/026988119500900210
Abstract
We report four people with human immunodeficiency virus (HIV) infection and mania whose manic symptoms improved when given the atypical antipsychotic agent remoxipride as an adjunct, and in whom traditional neuroleptics were not well tolerated due to marked extrapyramidal side effects. General issues surrounding choice of pharmacological agent in HIV-related mania are discussed.Keywords
This publication has 16 references indexed in Scilit:
- Anticonvulsant use in the treatment of manic syndromes in patients with HIV-1 infectionThe Journal of Neuropsychiatry and Clinical Neurosciences, 1993
- Reduced basal ganglia volume in HIV‐1‐associated dementiaNeurology, 1993
- Subcortical dementia.BMJ, 1993
- Manic syndrome early and late in the course of HIVAmerican Journal of Psychiatry, 1993
- Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairmentNeurology, 1993
- AIDS dementia-related psychosis: Is there a window of vulnerability?AIDS Care, 1992
- Excitotoxicity and Dopaminergic Dysfunction in the Acquired Immunodeficiency Syndrome Dementia ComplexArchives of Neurology, 1991
- Psychiatric Illnesses in Patients with HIV Infection and AIDS Referred to the Liaison PsychiatristThe British Journal of Psychiatry, 1991
- Manic syndrome in AIDSAmerican Journal of Psychiatry, 1991
- Clinical profile of remoxipride - a combined analysis of a comparative double-blind multicentre trial programmeActa Psychiatrica Scandinavica, 1990